Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme #946;-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer#39;s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|13|4|266-274

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.13, Iss.4, 2017-11, pp. : 266-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

By Recanatini Maurizio   Cavalli Andrea  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1853-1865

Informa Healthcare

Access to resources Recommend Favorite

Development of BACE1 Inhibitors for Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1811-1829

Bentham Science Publishers

Access to resources Recommend Favorite

Fighting Against Alzheimer#39;s Disease: Synthesis of New Pyrazoline and Benzothiazole Derivatives as New Acetylcholinesterase and MAO Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 4, 2018-03 ,pp. : 414-427

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1315-1324

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target for Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 661-670

Bentham Science Publishers

Access to resources Recommend Favorite